Managed Account Advisors’s Idexx Laboratories IDXX Stock Holding History

Managed Account Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$41.4M	Buy	644,924 +378	+0.1%	+$26.2K	0.03%	462
2015 Q1	$49.8M	Sell	644,546 -220,304	-25%	-$17.1M	0.04%	409
2014 Q4	$64.1M	Buy	864,850 +628,948	+267%	+$44.1M	0.06%	337
2014 Q3	$13.9M	Buy	235,902 +28,646	+14%	+$1.81M	0.02%	856
2014 Q2	$13.8M	Sell	207,256 -48,724	-19%	-$3.1M	0.02%	860
2014 Q1	$15.5M	Buy	255,980 +16,302	+7%	+$971K	0.02%	760
2013 Q4	$12.7M	Buy	239,678 +17,222	+8%	+$906K	0.02%	845
2013 Q3	$11.1M	Buy	222,456 +1,074	+0.5%	+$51.6K	0.02%	859
2013 Q2	$9.93M	Buy	+221,382	New	+$9.67M	0.02%	885

Other funds holding IDXX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.43B AUM 18.44% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Managed Account Advisors's IDXX Position: Q2 2015 in Review

Managed Account Advisors increased its Idexx Laboratories (IDXX) stake by 0.06% in Q2 2015, buying an estimated $26.2K and bringing the position to 644,924 shares worth $41.4M. The position accounts for 0.03% of the portfolio, ranked #462.

Managed Account Advisors first reported a position in IDXX in Q2 2013 and has held it in 9 quarters since. The position peaked at $64.1M in Q4 2014. 348 funds tracked by Wall St. Rank hold IDXX as of Q2 2015.

Managed Account Advisors held 644,924 shares of Idexx Laboratories worth $41.4M as of Q2 2015.
Managed Account Advisors bought 378 Idexx Laboratories shares in Q2 2015, an estimated $26.2K.
Idexx Laboratories made up 0.03% of Managed Account Advisors's portfolio in Q2 2015, its #462 holding.
Managed Account Advisors first reported a position in Idexx Laboratories in Q2 2013 and has held it in 9 quarters since.
Managed Account Advisors's Idexx Laboratories position peaked at $64.1M in Q4 2014.
348 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.